Thu, November 10, 2022

Ed Arce Maintained (ABUS) at Strong Buy with Decreased Target to $6 on, Nov 10th, 2022

Ed Arce of HC Wainwright & Co., Maintained "Arbutus Biopharma Corporation" (ABUS) at Strong Buy with Decreased Target from $7.5 to $6 on, Nov 10th, 2022.

Ed, nor any peers, have made any analyst calls on ABUS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30